News & Resources

How Pharma Communications Can Benefit From Virtual Meetings

Digital trends influence much of today’s marketing practices, and as they are applied to pharma communications, they can help inform robust engagement strategies.

Pharma companies should consider the benefits of incorporating virtual meetings into their HCP engagement campaigns. For one, virtual meetings can secure interaction with HCPs, especially when physician availability and access are prevailing obstacles for pharma companies today. This post will discuss how to lead virtual meetings with highly tailored content that encourages meaningful HCP engagement. Furthermore, we’ll touch on how to establish standards of clear communication and how to measure and analyze interactions from virtual meetings.

Select a facilitator to conduct virtual meetings as a strategy
The first strategy when conducting virtual meetings is to nominate a facilitator. This person can help execute a virtual meeting and ensure standards of communication are met in a larger, organizational context. But more than setting meeting objectives and establishing an agenda, the facilitator needs to be able to moderate the meeting and prompt a certain level of engagement among HCPs and pharma professionals. In order to motivate meeting participants, the facilitator should not only understand the team’s communication preferences, but also should be extremely knowledgeable on the therapeutic area or medical topic of interest. Ideally, the facilitator would also have a medical background, such as nurse, physician, or researcher.

The role of facilitator is also important to make sure everyone is contributing and communicating effectively. Because the meeting venue is virtual, recognizing the value and participation of all members is integral to the meeting’s success. If individual members seem disengaged, a facilitator may use coaching programs as a tactic. A coaching program should support interaction with separate members, be adaptable to accommodate members from physically diverse locations, and elicit constructive feedback to improve future meetings.

Fit virtual meetings with targeted messaging and quality content
Use targeted messaging and quality content to enhance virtual opportunities for contact. Virtual meetings should not only offer the type of knowledge that HCPs desire, like information on the newest medical practices, but also invite participation using interactive features such as games or collaborative tasks. They can also provide HCPs the rare platform to interact with other KOLs and ask specific questions about new products or treatments. Interactive content and open discussion forums further create an opportunity to evaluate meeting interactions and hone your approach to targeted messaging.

A virtual meeting rich in high-quality content typically encourages attendees to sign up to receive follow-up information. This presents a secondary opportunity for pharma communications teams to deliver syndicated content, share important clinical findings, and reinforce the marketing message. An email with measurable interactive content, for example a video link, can be used to further track who views the video and for how long. (According to a recent report on the consumption of digital sources by physicians, HCPs are said to spend around 3 hours a week just watching professional videos.)

Virtual meetings require clear, consistent standards of communication
The success of a virtual meeting depends on regular, clear, and timely communication by members, which should be promoted as a standard of seamless information-sharing. When members are spread throughout the world, clear communication standards are necessary to keep everyone in the loop. With a coherent set of rules, conflicts of communication can be resolved quickly in order to avoid interrupting the flow of information. In addition to advocating some sense of logistics order, consistent standards of communication ultimately help build better relationships among team members and create more quality engagement opportunities.

Measure HCP engagement by analyzing meeting participation
Another benefit of virtual meetings is the ability to evaluate and measure HCP engagement through platform metrics and by analyzing meeting notes and commentary. As mentioned, meeting hosts may further prompt attendees to continue the discussion and sign up to receive future communications. Measurable, interactive content included in these postmeeting communications can be used to help understand the interests of HCPs and other attendees. The ability to measure and analyze virtual meeting participation ultimately helps you tailor your message and gain insight into what information may be valuable to include in future meetings or workshops.

Virtual meetings not only embrace the technologic shift in marketing practices, but they also support syndicated content delivery and overall pharma communications strategies. They are much more convenient to arrange than face-to-face meetings, and are proving to be more cost-effective. Most importantly, it is thought that virtual meetings yield better HCP engagement due to scheduling convenience and accessibility to a more comprehensive well of information. With the convenience of virtual meetings, HCPs also experience improved ability and time allocation to see and treat patients.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.